Clinical Trial Update: N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating N-acetylcysteine and milk thistle for diabetic nephropathy has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Proteinuria

Drugs mentioned

• Milk Thistle (silymarin)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Diabetic Nephropathy, Proteinuria | Phase 2 | Status: COMPLETED | Results posted: 2017-03-31